ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc.verified

PMN

Price:

$10.35

Market Cap:

$13.53M

ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, tar...[Read more]

Industry

Biotechnology

IPO Date

2007-01-10

Stock Exchange

NASDAQ

Ticker

PMN

The Current Ratio as of June 2026 (TTM) for ProMIS Neurosciences, Inc. (PMN) is 9.92

According to ProMIS Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.92. This represents a change of 193.33% compared to the average of 3.38 of the last 4 quarters.

ProMIS Neurosciences, Inc. (PMN) Historical Current Ratio (quarterly & annually)

How has PMN Current Ratio performed in the past?

The mean historical Current Ratio of ProMIS Neurosciences, Inc. over the last ten years is 3.77. The current 9.92 Current Ratio has changed 26.20% with respect to the historical average. Over the past ten years (40 quarters), PMN's Current Ratio was at its highest in in the December 2021 quarter at 19.07. The Current Ratio was at its lowest in in the June 2023 quarter at 0.17.

Quarterly (TTM)
Annual

Average

3.77

Median

1.33

Minimum

0.52

Maximum

19.07

ProMIS Neurosciences, Inc. (PMN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ProMIS Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.59%

Maximum Annual Current Ratio = 19.07

Minimum Annual Increase = -94.35%

Minimum Annual Current Ratio = 0.52

Quarterly (TTM)
Annual
YearCurrent RatioChange
20250.88-89.65%
20248.52485.23%
20231.4635.32%
20221.08-94.35%
202119.073.59%
20200.52-57.25%
20191.21-24.80%
20181.61-38.85%
20172.63253.65%
20160.74-61.88%

ProMIS Neurosciences, Inc. (PMN) Average Current Ratio

How has PMN Current Ratio performed in the past?

The current Current Ratio of ProMIS Neurosciences, Inc. (PMN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.62

5-year avg

6.20

10-year avg

3.77

ProMIS Neurosciences, Inc. (PMN) Current Ratio vs. Peers

How is PMN’s Current Ratio compared to its peers?

ProMIS Neurosciences, Inc.’s Current Ratio is less than MapLight Therapeutics, Inc. (22.91), greater than Ernexa Therapeutics Inc. (2.89), greater than OSR Holdings, Inc. (0.16), less than Lipocine Inc. (9.99), greater than Adaptimmune Therapeutics plc (1.52), greater than Edesa Biotech, Inc. (4.76), greater than Adlai Nortye Ltd. (0.65), greater than GeoVax Labs, Inc. (1.06), less than Tharimmune, Inc. (37.75), greater than BioRestorative Therapies, Inc. (2.35),

Build a custom stock screener for ProMIS Neurosciences, Inc. (PMN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProMIS Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProMIS Neurosciences, Inc. (PMN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProMIS Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is ProMIS Neurosciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for ProMIS Neurosciences, Inc. (PMN)?

What is the highest Current Ratio for ProMIS Neurosciences, Inc. (PMN)?

What is the 3-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?

What is the 5-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?

How does the current Current Ratio for ProMIS Neurosciences, Inc. (PMN) compare to its historical average?